WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea · Delayed Price · Currency is KRW 9,760.00
+190.00 (1.99%)
At close: Apr 20, 2026
KOSDAQ:330350 Market Cap
KOSDAQ:330350 has a market cap or net worth of 129.51 billion as of April 21, 2026. Its market cap has increased by 61.88% in one year.
Market Cap
129.51B
Enterprise Value
128.80B
Revenue
106.44B
Ranking
n/a
PE Ratio
26.09
Stock Price
9,760.00
Market Cap Chart
Since July 3, 2020, KOSDAQ:330350's market cap has decreased from 302.46B to 129.51B, a decrease of -57.18%. That is a compound annual growth rate of -13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 128.85B | 13.23% |
| Dec 30, 2025 | 113.80B | 22.44% |
| Dec 30, 2024 | 92.94B | -27.60% |
| Dec 28, 2023 | 128.37B | 3.84% |
| Dec 29, 2022 | 123.62B | -10.73% |
| Dec 30, 2021 | 138.48B | -26.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 155.09B |
| Kyung Dong Pharmaceutical | 154.11B |
| DongKoo Bio & Pharma | 145.49B |
| PHARMARESEARCH BIO | 140.47B |
| KOREA PHARMA | 132.84B |
| HYUNDAI BIOLAND | 131.40B |
| Pharos iBio | 124.15B |
| Daehan Nupharm | 105.26B |